Evidence map›Paper›PMID 20399103›Full record

ReviewTrends in biochemical sciences2010

The extended PP1 toolkit: designed to create specificity.

Mathieu Bollen, Wolfgang Peti, Michael J Ragusa, Monique Beullens

Open access · greenAbstract readReview
In one paragraph

Review in Trends in biochemical sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 296 papers.

0numbers the graph read from it
0cells of the map it votes in
296citing papers in PubMed
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

296 citing papers in PubMed, 515 citations in OpenAlex.

  1. Concurrent or sequential letrozole with adjuvant breast radiotherapy: final results of the CO-HO-RT phase II randomized trial.Annals of oncology : official journal of the European Society for Medical Oncology · 2016
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Characterization of the Regulatory AAA-ATPase Subunit Rpt3 inInternational journal of molecular sciences · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Fuzziness in enzymatic catalysis.Current opinion in structural biology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Review

236 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mathieu BollenLaboratory of Biosignaling & Therapeutics, Department of Molecular Cell Biology, University of Leuven, B-3000 Leuven, Belgium. Mathieu.Bollen@med.kuleuven.be
Wolfgang Peti
Michael J Ragusa
Monique Beullens
Brown University · USKU Leuven · BE

Funding

TRAINING IN MOLECULAR &CELL BIOLOGY &BIOCHEMISTRYT32GM007601 · NIGMS · BROWN UNIVERSITY · PI MOWRY, KIMBERLY L. · 1985 to 2019
$6.4M
Structural and Functional Analysis of Signaling Proteins in Dendritic SpinesR01NS056128 · NINDS · BROWN UNIVERSITY · PI PETI, WOLFGANG · 2007 to 2011
$1.7M
NIGMS NIH HHS T32 GM007601NINDS NIH HHS R01 NS056128NINDS NIH HHS R01NS056128
6 · The paper itself

Abstract

Protein Ser/Thr phosphatase-1 (PP1) catalyzes the majority of eukaryotic protein dephosphorylation reactions in a highly regulated and selective manner. Recent studies have identified an unusually diversified PP1 interactome with the properties of a regulatory toolkit. PP1-interacting proteins (PIPs) function as targeting subunits, substrates and/or inhibitors. As targeting subunits, PIPs contribute to substrate selection by bringing PP1 into the vicinity of specific substrates and by modulating substrate specificity via additional substrate docking sites or blocking substrate-binding channels. Many of the nearly 200 established mammalian PIPs are predicted to be intrinsically disordered, a property that facilitates their binding to a large surface area of PP1 via multiple docking motifs. These novel insights offer perspectives for the therapeutic targeting of PP1 by interfering with the binding of PIPs or substrates.

Indexed as

Catalytic DomainAmino Acid MotifsAnimalsModels, MolecularProtein BindingProtein Phosphatase 1Substrate SpecificityProtein Phosphatase 1

Identifiers

PMID20399103
PMCPMC3131691
OpenAlexW1996286498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.